MODIFICATION
A -- Luminex Corporation ARIES SARS-CoV-2 FDA 510(k) Clearance
- Notice Date
- 9/30/2022 7:06:30 AM
- Notice Type
- Justification
- NAICS
- 541715
— Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Contracting Office
- BARDA - ASPR / DAAPPO / BARDA DCMA WASHINGTON DC 20515 USA
- ZIP Code
- 20515
- Solicitation Number
- 75A50122P00023
- Archive Date
- 10/30/2022
- Point of Contact
- Davis Perkins, Amber Gray
- E-Mail Address
-
davis.perkins@hhs.gov, amber.gray@hhs.gov
(davis.perkins@hhs.gov, amber.gray@hhs.gov)
- Award Number
- 75A50122P00023
- Award Date
- 09/21/2022
- Description
- The Government procured the required clinical and development services to obtain U.S. Food and Drug Administration (FDA) Section 510(k) clearance of Luminex Corporation�s combined ARIES � Flu A/B/RSV + Coronavirus (SARS-CoV-2 test using simplified acquisition procedures. FDA 510(k) clearance will allow Luminex to commercially market their combined SARS-CoV-2, influenza A, influenza B, and Respiratory syncytial virus (RSV) diagnostic test that operate on the proprietary ARIES� platform.
- Web Link
-
SAM.gov Permalink
(https://sam.gov/opp/dd337c78405c427489a03a0199ecaa19/view)
- Place of Performance
- Address: Austin, TX 78727, USA
- Zip Code: 78727
- Country: USA
- Zip Code: 78727
- Record
- SN06483623-F 20221002/220930230108 (samdaily.us)
- Source
-
SAM.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's SAM Daily Index Page |